Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thoracic Paravertebral Blockade for Pain After VATS
NCT02302586Phase 4Completed
- Sponsor
- Istanbul University
- Start
- Sep 2014
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (2 arms), sponsored by Istanbul University. Primary endpoint: Postoperative chronic pain scores (VAS) at 6 months. Started Sep 2014; status: completed.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02302586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02302586.